Journals / Eastern Journal of Medicine / 2016 / Cilt: 21 - Sayı: 4

The protective role of resveratrol on serum total sialic acid and lipid-bound sialic acid in female rats with chronic fluorosis

Pages
168–172
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The present study demonstrated slight positive and beneficial effect of resveratrol on the concentration levels of LSA and TSA in serum.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In the present study, the effect of resveratrol on serum total sialic acid (TSA) and lipid bound sialic acid (LSA) was investigated in the rats exposed to chronic fluoride.
📊
Key Findings & Data:The study was administered using 32 female Sprague Dawley rats weighing 200-250 g.
💡
Conclusion & Impact:The present study demonstrated slight positive and beneficial effect of resveratrol on the concentration levels of LSA and TSA in serum.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In the present study, the effect of resveratrol on serum total sialic acid (TSA) and lipid bound sialic acid (LSA) was investigated in the rats exposed to chronic fluoride. The study was administered using 32 female Sprague Dawley rats weighing 200-250 g. Rats were divided into four groups (n=8/group). Group I comprised the control group, group II was treated with sodium fluoride (NaF) (10 mg/L/day), group III was treated with resveratrol (50 mg/L/day) and group IV was treated with NaF+resveratrol for 90 days period. Total sialic acid (TSA) and lipid-bound sialic acid (LSA) were determined in serum samples. Statistical analysis showed that the NaF group was significantly higher than the control group with regards to LSA (17.59±2.734 mg/dL, 12.61±2.013 mg/dL) and TSA (87.86± 8.34 mg/dL, 71.47± 8.57 mg/dL) levels (p<0.01 and p<0.05 respectively). Whereas the Resveratrol group was also significantly lower than the NaF group regarding LSA (13.21±2.848 mg/dL, 17.59±2.734 mg/dL) and TSA (72.44± 10.43 mg/dL, 87.86± 8.34 mg/dL) levels (p<0.05 and p<0.05 respectively), Moreover, no significant differences in LSA (14.62±1.85 mg/dL, 12.61±2.013 mg/dL) and TSA (81.19 ±10.24 mg/dL, 71.47± 8.57 mg/dL) levels were observed in the Resveratrol + NaF groups, as compared to the control group (p>0.05). The present study demonstrated slight positive and beneficial effect of resveratrol on the concentration levels of LSA and TSA in serum.

🔖

Cite This Article

OTO, G. (2016). The protective role of resveratrol on serum total sialic acid and lipid-bound sialic acid in female rats with chronic fluorosis. Eastern Journal of Medicine, Cilt: 21 - Sayı: 4, 168–172. https://ajindex.com/articles/222603

References (16)

  1. Demirel Ü, Delibaşı T, Aren G. Effect of HighFluoride Water on Different Body Parts in Huma. Journal of Istanbul University Faculty of Dentistry 2012; 3: 79-90
  2. Kaya S, Sanlı Y, Pirinçci İ, et al. Veterinary Clinical Toxicology, Medisan Press Ankara 1995; 2: 80-85
  3. Ghada AA, Eman FK, Dalia GM, Lydia KE. Neuroprotective effect of resveratrol against brain ischemia reperfusioninjury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/GSK3b survival pathway. Archives of Physiology and Biochemistry 2016; 1-14: 1381-3455
  4. Gen K, Takanobu O, Naohıro Y, et al. Resveratrol suppresses TGF-?-induced VEGF synthesis in osteoblasts: Inhibition of the p44/p42 MAPK and SAPK/JNK pathways. Experimental and therapeutic medicine 2015; 9: 2303-2310
  5. Mary L, Robert JD, Raghu V. Resveratrol Neuroprotection in Stroke and Traumatic CNS injury. Neurochemisty International 2015; 89: 75-82
  6. Shang YJ, Qian YP, Liu XD, et al. Radical-scavenging activity and mechanism of resveratrol-oriented analogues: influence of the solvent, radical, and substitution. The Journal of organic chemistry 2009; 74: 5025-5031
  7. Guohua H, Jufeng X, Jianjun G, et al. Anti-tumor effects and cellular mechanisms of resveratrol. Drug Discoveries & Therapeutics 2015; 9: 1-12
  8. Dominique BR. Resveratrol and Cardiovascular Diseases. Nutrients 2016; 8: 1-24
  9. Sumitra G, Mithun R, Anand CVR. Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome. Journal of Clinical and Diagnostic Research 2016; 10: 9-13
  10. Cemal K, Ufuk U, Selma SG. Total and LipidBound Sialic Acid Levels in Experimental Myocardial Infarction. Journal of Turkish Clinical Biochemistry 2009; 7: 7-15
  11. Kelm S, Schauer R. Sialic acids in molecular and cellular interactions. International Review of Cytology 1997; 175: 137-240
  12. Surapaneni KM, Vishnu P. Serum total sialic acid, lipid peroxidation, and glutathione reductase levels in patients with rheumatoid arthritis. Turkish Journal of of Medical Sciences 2010; 40: 537-540
  13. Ezel U, Deniz G, Osman Y. larynx Cancer and Sialic acid as a Prognostic Factor. Journal of Turkish oncology. 2004; 4: 140-143
  14. Nigam PK, Narain VS, Ajay K. Sialic acid in cardiovascular diseases. Indian Journal of Clinical Biochemistry 2006; 21: 54-61
  15. Sydow GA. Simplified Quick Method for Determination of Sialic Acid in Serum, Biochemica Acta 1985; 44: 1721-1723
  16. Katapodis N, Hirshaut Y, Geller NL, Stock CC. Lipid-A